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Abstract
Background: India accounts for one-fifth of the global incident cases of tuberculosis(TB). The country presently has 
the world's largest directly observed treatment, short course (DOTS) programme, that has shown impressive results 
and covers almost 100% of the billion-plus Indian population. Despite such a successful programme, the majority of 
Indian patients with tuberculosis prefer private healthcare, although repeated audits of this sector have shown the 
quality to be poor.
We aimed to ascertain the level of awareness and knowledge of private patients with tuberculosis attending our clinic
at a tertiary private healthcare institute with regards to the DOTS programme, understanding the reasons behind their
preference for private healthcare, and evaluating their perceptions and reasons for accepting or failing to accept
directly observed therapy as a treatment option.
Methods: A structured interview schedule was administered to private patients with tuberculosis at the P.D. Hinduja 
Hospital and Medical Research Centre, Mumbai, India between January 2006 to November 2007.
Results: Only 30 of 200 patients (15%) were aware of the DOTS programme. After being explained what directly 
observed therapy was, 136 patients (68%) found this form of treatment unacceptable.183 patients (91.5%) preferred 
buying the drugs themselves to visiting a DOTS centre. 90 patients (45%) were not prepared to be observed while 
swallowing their TB drugs, finding it an intrusion of privacy.
Conclusions: Our study reveals a poor knowledge and awareness of the DOTS programme among the cohort of TB 
patients that we interviewed. The control of TB in India will undoubtedly benefit from more patients being attracted to 
and treated by the existing DOTS programmes. However, directly observed treatment, in its present form, is considered 
too rigid and intrusive and is unlikely to be accepted by a majority of patients seeking private healthcare. Novel 
strategies and more flexible options will have to be devised to ensure higher cure rates without compromising patient 
choice.
Background
Tuberculosis (TB) is the seventh most common cause of
mortality worldwide [1], and Indian patients account for
one-fifth of the global incident cases of TB; 1.8 million
new cases occur every year [2] It is one of the commonest
infectious diseases in India and has caused significant
morbidity, mortality and untold suffering in this country
over the decades. The Annual Risk of Tuberculosis Infec-
tion (ARI) has been estimated to be about 1.5-1.7%, the
risk being significantly higher in urban areas [3]. The
Revised National Tuberculosis Control Programme
(RNTCP) was formally launched in 1998, directly
observed treatment, short-course (DOTS) being the cor-
nerstone of the programme. The programme is presently
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Page 2 of 5the world's largest DOTS programme, covering almost
100% of the billion-plus Indian population [4]. In the
cohort of patients treated with DOTS, akin to the experi-
ence of other countries around the world, the programme
has shown impressive results in various criteria: case
detection, treatment outcomes, and lower rates of failure,
default and death.
Despite critiques finding the treatment offered in the
private health sector to be unsound, sub-standard and
inconsistent, 50-70% of tuberculosis patients in India
continue to prefer private healthcare [5-7]. These patients
are not monitored by the RNTCP and therefore, do not
benefit from the potential success rates offered by DOTS.
The further success of TB control in India will signifi-
cantly depend on attracting these patients, and compre-
hending the reasons for the inability of a successful
programme to be considered as the health provider of
choice by the masses.
Our study aims at analyzing the awareness and knowl-
edge of private patients with tuberculosis attending our
clinic at a tertiary private healthcare institute with
regards to the DOTS programme, understanding the rea-
sons behind their preference for private healthcare, and
evaluating their perceptions and reasons for accepting or
failing to accept directly observed treatment (DOT) as a
treatment option.
Methods
The study was conducted at a large private hospital in
Mumbai, India where all attending patients pay out-of-
pocket for consultations. The hospital caters to a large
suburban population of Mumbai city, and has a busy
chest department, that serves approximately 60 patients a
day. The treatment of tuberculosis at the hospital involves
consulting the treating physician on a flexible basis for
monitoring and fresh prescriptions. Although private-
public mixes (PPMs) have been successful in various
studies across the country, the hospital is not a part of any
public-private mix (PPM) project; hence patients are not
offered DOT as a treatment modality.
200 consecutive adult patients with a diagnosis of
tuberculosis who opted to visit one of the authors, a pri-
vate chest physician, in the outpatients department of the
hospital between January 2006 to November 2007 were
enrolled in the study at the time of diagnosis. The study
was approved by the "P.D. Hinduja national hospital and
medical research centre institutional review board",
which is the ethics committee of the hospital. A written
informed consent was taken from the patients at the time
of enrollment. There were no incentives offered for the
enrollment, and patients could choose to be anonymous.
All of the 200 patients who enrolled consented to being
part of the study and were then recruited.
At their second follow-up visit, a structured interview
schedule was used to administer a four-part question-
naire covering their demographic features, followed by an
assessment of their knowledge, attitude and practice
regarding the choices in the treatment of tuberculosis
(Annex 1, for the detailed questionnaire, see Annex 3).
The questionnaire was administered by a physician or
medical personnel trained to understand the intricacies
of the DOTS programme; patients were at liberty to ask
questions on aspects that needed further elaboration. In
the event that a patient was unaware of DOTS, the inter-
viewer explained the tenets of the programme and then
evaluated the patient's attitudes and acceptability. The
explanation offered included a detailed elaboration of the
five key elements of DOTS. On an average, each inter-
view lasted 30 minutes.
Results
The patient sample included in our study comprised pre-
dominantly middle-aged, economically productive indi-
viduals. Over 90 percent of interviewed patients had at
least a secondary school education, which corresponds to
a minimum of seven years of formal schooling. The
median family income was significantly above the
national average. The demographic characteristics of the
patients are summarized in Table 1. The overall
responses to the interview are summarized in Table 2.
When asked whether they were aware of a new strategy
to fight TB called DOTS, only 30 patients (15%) replied in
the affirmative. Only 1 of the 200 patients (0.5%) could
expand the DOTS abbreviation accurately, while 5
patients (2.5%) were only vaguely aware of what DOTS
entailed.
After being explained what DOT entailed, each patient
was asked if and why he/she found this form of treatment
acceptable. The majority of private patients (136 out of
200, 68%) found this form of treatment unacceptable; the
commonest reason cited (80/200, 40%) was that three vis-
its to a clinic per week were cumbersome, time-consum-
ing and inconvenient. The other reasons cited were the
perceived poor quality of treatment offered by services
that involved the government (26/200, 13%) and the lack
of privacy (6/200, 3%). When asked why they preferred a
private TB specialist to a government TB clinic, 136
patients (68%) had reservations about the quality of
healthcare offered in government hospitals, with a gen-
eral lack of trust in government services, lack of attention
offered to patients, long waits, poor hygiene and suspect
quality of drugs being cited as reasons. 50 patients (25%)
chose private care based on word-of-mouth experiences,
past experiences or a referral from their family physician.
Only 64 patients (32%) found DOT acceptable, the com-
monest reasons for perceiving it as a sound treatment
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15%), that it was offered free (13/200 respondents, 6.5%)
and guaranteed a complete supply of drugs (6/200
respondents, 3%).
When asked whether they themselves would be pre-
pared to visit a TB clinic as frequently as thrice a week to
receive drugs, only 51 patients (25.5%) answered in the
affirmative. However, when specifically asked their
choice, 183 patients (91.5%) stated that they would still
prefer buying the drugs themselves once a month. 90
patients (45%) were not prepared to have a doctor or
nurse actually observe them swallow each dose of their
TB drugs, claiming this amounted to an intrusion of their
privacy. The commonest reason given for not wanting to
be supervised was that they were responsible individuals
and knew the importance of taking their drugs as advised
(36/200 respondents, 18%). A few responses that, while
standing out in terms of clarity, reflected the overall sen-
timent have been summarized in Annex 2.
Discussion
The DOTS programme in India is a highly successful one,
covering India's billion-plus population [4]. Despite the
success of the programme, 60-88 percent of Indian
patients with tuberculosis choose to bypass the public
health system completely and consult a private medical
practitioner for treatment [8]. Drug marketing surveys
indicate that 94 million dollars worth of antituberculous
drugs were purchased in India in the year 2006; approxi-
mately 75 per cent of these drugs were procured from the
private sector [9]. These figures are not limited to the
urban patients; a recent survey in the slums of Bangalore
suggested that up to 72% of patients with pulmonary
tuberculosis first approached a private healthcare facility
for treatment [10]. India has a huge, unwieldy, and poorly
regulated private medical sector with an estimated 10
million registered doctors, with a ratio of 1 doctor per
1000 population, far in excess of the WHO guideline of 1
in 3000. Around 50% of these are qualified and registered
non-allopathic doctors practicing alternative systems of
medicine such as homeopathy, ayurveda, and unani [11].
The TB prescribing practice of these doctors has been
found to be erratic and the majority of prescriptions do
not comply with standard guidelines [7]. India has the
second largest population of multi-drug resistant tuber-
culosis (MDR-TB) patients in the world [12]. A recent
study in Mumbai found MDR-TB prevalence rates to be
24% among newly diagnosed, previously untreated
patients and rates of 41% in first-line drug failures[13].
Approximately 8.4 million dollars worth of second line
antituberculous drugs were purchased in the year 2006;
almost all of it by the private sector[9]. A study conducted
by us found that among 106 practicing general practitio-
ners at a large slum in Mumbai who participated in the
questionnaire-based study, only 6 physicians could write
a correct prescription for a newly diagnosed patient of
tuberculosis [14]. There is little doubt that the poor pre-
scribing practices of physicians in the private sector fuel
the MDR-TB epidemic as well.
Knowledge and awareness of DOTS and its success
would be the first step in dispelling a patient's stereotypic
views of the public healthcare system. Our study high-
lights lacunae in public awareness of DOTS. Even
amongst our cohort of economically productive, edu-
cated Indians, only one patient (0.5%) could expand the
DOTS abbreviation, and 5 patients (2.5%) were vaguely
aware of what DOTS entailed. Only 30 of 200 private TB
patients (15%) were even aware of the government using a
strategy called DOTS in the fight to control TB in India.
Similar results were obtained at a pilot study of an infor-
mation, education and communication (IEC) campaign
in Delhi, India, that found the knowledge of the people
concerning tuberculosis and DOTS to be grossly lacking.
While the level of awareness and a change in help-seeking
behavior did change after the pilot IEC campaign, the
change was primarily among the literate and those from a
higher economic stratum [15]. The demographic profile
of our patients comprised predominantly literate, middle-
income individuals. Even in such a cohort, in a metropol-
itan city like Mumbai with almost universal access to tele-
vision, the knowledge regarding DOTS was dismal,
highlighting the government's failure to increase public
awareness through information campaigns. It is essential
to involve and sensitize the private healthcare in India in
the fight against TB. The DOTS strategy and implemen-
tation of new strategies are essential in fighting the dis-
ease. Several existing PPMs have performed well [16,17],
and these augur well for further success of such pro-
grammes, contributing significantly to the control of TB
in India, if instituted in a systematic and planned manner.
An overwhelming 91.5% of the patients interviewed
preferred purchasing the drugs themselves instead of
enrolling in the DOTS programme. Traveling to a treat-
ment center thrice a week in the midst of busy schedules
in a traffic congested city like Mumbai seemed impracti-
cal to the majority of patients. These reasons have been
identified in other studies as impediments to patient
acceptability [18,19]. Moreover, the risks of transmission
of TB in crowded waiting rooms at DOTS centres and the
apprehensions of the same have to be acknowledged and
should encourage the development of innovative strate-
gies such as family-member observed DOTS, which is an
inexpensive strategy that has been shown to be successful
[20]. Most of the patients in our study, being literate and
knowledgeable about the grave nature of their disease,
considered themselves responsible enough to not need
supervision while consuming medications, and therefore,
did not find the prospect of consuming medications
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perceive being supervised as equated to being considered
irresponsible, this is unlikely to change.
"Can I afford free treatment" was the provocative ques-
tion asked by Lonroth et al. in a study analyzing the pref-
erence for private healthcare among patients with
tuberculosis in Ho Chi Minh City, Vietnam [21]. The
patients in our study seem to reflect a similar sentiment,
with perceptions of the public healthcare system being
predominantly negative, and indicative of a lack of trust
in the care offered; the risk of being treated inappropri-
ately being perceived as too high to offset the lure of free
treatment. Such perceptions warrant serious introspec-
tion on identifying shortcomings and analyzing ways of
improving the brand equity of services that involve the
public sector.
A social assessment study submitted to the Central TB
Division, Ministry of Health and Family welfare, Govern-
ment of India, found that even among poor, marginalized
groups consisting tribals, industrial workers, slum dwell-
ers, and migrant populations, Government health ser-
vices were sought as a last resort, often when financial
resources had been exhausted by treatment by private
practitioners, or the expensive laboratory tests ordered
by the private practitioners. The reasons cited for prefer-
ring private care were proximity (and therefore, costs
saved on transportation), flexibility and better attention
given [22]. A thorough Pubmed search, coupled with a
search of Indian medical journals failed to come up with a
similar study offering an in-depth analysis of the knowl-
edge and attitudes among urban TB patients affording of
private health care toward healthcare offered through the
public sector via the DOTS programme. Our study aims
to fill this void and offer a perspective on why so many
patients prefer to go private.
A shortcoming of our study is that the demographic
profile of the patients included is not representative of all
tuberculosis patients reporting to private clinics. 50-70%
of all TB patients prefer private healthcare, but this
cohort is likely to be more heterogeneous than our sam-
ple in terms of economic backgrounds and education.
Moreover, as a majority of the patients in our study were
from higher socioeconomic strata, the free treatment
offered by the DOTS programme may be less appealing
to the patients in our study than it would be to the general
population of patients.
Conclusions
'Concordance' is defined as "the creation of an agreement
between patient and healthcare provider about whether,
when and how medicines are to be taken" [23]. Concor-
dance is a cornerstone in the successful implementation
of any healthcare programme, and more so in a pro-
gramme such as DOTS, that demands a significant com-
mitment from the patient in terms of time and resources.
The control of TB in India will undoubtedly benefit
from more patients being attracted to and treated by the
existing DOTS programme. However, our study reveals a
poor knowledge and awareness of DOTS even among the
better educated cohort of TB patients that we inter-
viewed. The acceptability of DOT among private patients
is an issue of "discordance" among providers and patients
that needs to be addressed. DOT, in its present form, is
considered too rigid and intrusive and is unlikely to be
accepted by a majority of patients seeking private health-
care. Novel strategies such as family member-supervised
DOTS [20] and DOTS offered through PPMs may be
more flexible options that could lead to higher cure rates
without compromising patient choice.
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